nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirabegron—BCHE—Triamcinolone—ankylosing spondylitis	0.158	0.164	CbGbCtD
Mirabegron—SLCO1A2—Prednisolone—ankylosing spondylitis	0.125	0.13	CbGbCtD
Mirabegron—SLCO1A2—Prednisone—ankylosing spondylitis	0.118	0.123	CbGbCtD
Mirabegron—SLCO1A2—Dexamethasone—ankylosing spondylitis	0.074	0.0768	CbGbCtD
Mirabegron—ALB—Prednisone—ankylosing spondylitis	0.0612	0.0636	CbGbCtD
Mirabegron—SLCO1A2—Methotrexate—ankylosing spondylitis	0.0594	0.0617	CbGbCtD
Mirabegron—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0529	0.0549	CbGbCtD
Mirabegron—ABCB1—Betamethasone—ankylosing spondylitis	0.0344	0.0357	CbGbCtD
Mirabegron—ABCB1—Prednisolone—ankylosing spondylitis	0.0339	0.0352	CbGbCtD
Mirabegron—ABCB1—Prednisone—ankylosing spondylitis	0.032	0.0333	CbGbCtD
Mirabegron—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0317	0.0329	CbGbCtD
Mirabegron—ALB—Methotrexate—ankylosing spondylitis	0.0307	0.0319	CbGbCtD
Mirabegron—CYP3A4—Triamcinolone—ankylosing spondylitis	0.024	0.0249	CbGbCtD
Mirabegron—CYP3A4—Betamethasone—ankylosing spondylitis	0.0206	0.0214	CbGbCtD
Mirabegron—CYP3A4—Prednisolone—ankylosing spondylitis	0.0203	0.0211	CbGbCtD
Mirabegron—ABCB1—Dexamethasone—ankylosing spondylitis	0.02	0.0208	CbGbCtD
Mirabegron—CYP3A4—Prednisone—ankylosing spondylitis	0.0192	0.0199	CbGbCtD
Mirabegron—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0188	0.0196	CbGbCtD
Mirabegron—ABCB1—Methotrexate—ankylosing spondylitis	0.0161	0.0167	CbGbCtD
Mirabegron—CYP3A4—Dexamethasone—ankylosing spondylitis	0.012	0.0124	CbGbCtD
Mirabegron—Glaucoma—Prednisolone—ankylosing spondylitis	0.000794	0.0214	CcSEcCtD
Mirabegron—Leukocytoclastic vasculitis—Methotrexate—ankylosing spondylitis	0.00074	0.0199	CcSEcCtD
Mirabegron—Glaucoma—Triamcinolone—ankylosing spondylitis	0.00073	0.0197	CcSEcCtD
Mirabegron—Glaucoma—Methylprednisolone—ankylosing spondylitis	0.000728	0.0196	CcSEcCtD
Mirabegron—Glaucoma—Dexamethasone—ankylosing spondylitis	0.000662	0.0178	CcSEcCtD
Mirabegron—Glaucoma—Betamethasone—ankylosing spondylitis	0.000662	0.0178	CcSEcCtD
Mirabegron—Glaucoma—Prednisone—ankylosing spondylitis	0.000577	0.0155	CcSEcCtD
Mirabegron—Dry eye—Betamethasone—ankylosing spondylitis	0.000461	0.0124	CcSEcCtD
Mirabegron—Dry eye—Dexamethasone—ankylosing spondylitis	0.000461	0.0124	CcSEcCtD
Mirabegron—Vascular purpura—Triamcinolone—ankylosing spondylitis	0.000446	0.012	CcSEcCtD
Mirabegron—Osteoarthritis—Prednisolone—ankylosing spondylitis	0.000434	0.0117	CcSEcCtD
Mirabegron—Purpura—Triamcinolone—ankylosing spondylitis	0.000414	0.0112	CcSEcCtD
Mirabegron—Osteoarthritis—Triamcinolone—ankylosing spondylitis	0.000399	0.0107	CcSEcCtD
Mirabegron—Osteoarthritis—Methylprednisolone—ankylosing spondylitis	0.000398	0.0107	CcSEcCtD
Mirabegron—Abdominal distension—Prednisolone—ankylosing spondylitis	0.000377	0.0102	CcSEcCtD
Mirabegron—Osteoarthritis—Dexamethasone—ankylosing spondylitis	0.000362	0.00975	CcSEcCtD
Mirabegron—Osteoarthritis—Betamethasone—ankylosing spondylitis	0.000362	0.00975	CcSEcCtD
Mirabegron—Breast disorder—Methylprednisolone—ankylosing spondylitis	0.00036	0.00969	CcSEcCtD
Mirabegron—Cystitis noninfective—Methotrexate—ankylosing spondylitis	0.000354	0.00955	CcSEcCtD
Mirabegron—Vascular purpura—Prednisone—ankylosing spondylitis	0.000352	0.00949	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Methylprednisolone—ankylosing spondylitis	0.000351	0.00946	CcSEcCtD
Mirabegron—Cystitis—Methotrexate—ankylosing spondylitis	0.00035	0.00944	CcSEcCtD
Mirabegron—Abdominal distension—Triamcinolone—ankylosing spondylitis	0.000347	0.00935	CcSEcCtD
Mirabegron—Abdominal distension—Methylprednisolone—ankylosing spondylitis	0.000346	0.00933	CcSEcCtD
Mirabegron—Influenza—Triamcinolone—ankylosing spondylitis	0.000345	0.00929	CcSEcCtD
Mirabegron—Vaginal infection—Methotrexate—ankylosing spondylitis	0.000343	0.00923	CcSEcCtD
Mirabegron—Neoplasm—Methotrexate—ankylosing spondylitis	0.000328	0.00884	CcSEcCtD
Mirabegron—Bladder pain—Methotrexate—ankylosing spondylitis	0.000328	0.00884	CcSEcCtD
Mirabegron—Purpura—Prednisone—ankylosing spondylitis	0.000327	0.00881	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Triamcinolone—ankylosing spondylitis	0.00032	0.00863	CcSEcCtD
Mirabegron—Osteoarthritis—Prednisone—ankylosing spondylitis	0.000315	0.00849	CcSEcCtD
Mirabegron—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.000307	0.00826	CcSEcCtD
Mirabegron—Infestation—Methylprednisolone—ankylosing spondylitis	0.000307	0.00826	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Prednisone—ankylosing spondylitis	0.000278	0.00749	CcSEcCtD
Mirabegron—Rhinitis—Triamcinolone—ankylosing spondylitis	0.000277	0.00745	CcSEcCtD
Mirabegron—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.000276	0.00744	CcSEcCtD
Mirabegron—Abdominal distension—Prednisone—ankylosing spondylitis	0.000274	0.00739	CcSEcCtD
Mirabegron—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.000271	0.00729	CcSEcCtD
Mirabegron—Cerebrovascular accident—Methotrexate—ankylosing spondylitis	0.000269	0.00724	CcSEcCtD
Mirabegron—Osteoarthritis—Methotrexate—ankylosing spondylitis	0.000263	0.0071	CcSEcCtD
Mirabegron—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.000257	0.00693	CcSEcCtD
Mirabegron—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.000256	0.00689	CcSEcCtD
Mirabegron—Vision blurred—Prednisolone—ankylosing spondylitis	0.000246	0.00663	CcSEcCtD
Mirabegron—Breast disorder—Methotrexate—ankylosing spondylitis	0.000238	0.00641	CcSEcCtD
Mirabegron—Eye disorder—Betamethasone—ankylosing spondylitis	0.000234	0.0063	CcSEcCtD
Mirabegron—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000234	0.0063	CcSEcCtD
Mirabegron—Back pain—Triamcinolone—ankylosing spondylitis	0.000232	0.00626	CcSEcCtD
Mirabegron—Hypertension—Prednisolone—ankylosing spondylitis	0.000226	0.00608	CcSEcCtD
Mirabegron—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000214	0.00577	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000212	0.0057	CcSEcCtD
Mirabegron—Tachycardia—Prednisolone—ankylosing spondylitis	0.000208	0.00561	CcSEcCtD
Mirabegron—Hypertension—Triamcinolone—ankylosing spondylitis	0.000207	0.00559	CcSEcCtD
Mirabegron—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000207	0.00558	CcSEcCtD
Mirabegron—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000204	0.0055	CcSEcCtD
Mirabegron—Eye disorder—Prednisone—ankylosing spondylitis	0.000204	0.00549	CcSEcCtD
Mirabegron—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000203	0.00547	CcSEcCtD
Mirabegron—Infestation—Methotrexate—ankylosing spondylitis	0.000203	0.00547	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000203	0.00546	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000201	0.00542	CcSEcCtD
Mirabegron—Dry mouth—Triamcinolone—ankylosing spondylitis	0.0002	0.00539	CcSEcCtD
Mirabegron—Infection—Triamcinolone—ankylosing spondylitis	0.000195	0.00525	CcSEcCtD
Mirabegron—Infection—Methylprednisolone—ankylosing spondylitis	0.000194	0.00524	CcSEcCtD
Mirabegron—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000191	0.00516	CcSEcCtD
Mirabegron—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000191	0.00514	CcSEcCtD
Mirabegron—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00019	0.00512	CcSEcCtD
Mirabegron—Hypertension—Betamethasone—ankylosing spondylitis	0.000188	0.00507	CcSEcCtD
Mirabegron—Hypertension—Dexamethasone—ankylosing spondylitis	0.000188	0.00507	CcSEcCtD
Mirabegron—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00018	0.00485	CcSEcCtD
Mirabegron—Vision blurred—Prednisone—ankylosing spondylitis	0.000179	0.00482	CcSEcCtD
Mirabegron—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000179	0.00481	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000179	0.00481	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000178	0.0048	CcSEcCtD
Mirabegron—Infection—Dexamethasone—ankylosing spondylitis	0.000177	0.00476	CcSEcCtD
Mirabegron—Infection—Betamethasone—ankylosing spondylitis	0.000177	0.00476	CcSEcCtD
Mirabegron—Tachycardia—Betamethasone—ankylosing spondylitis	0.000174	0.00468	CcSEcCtD
Mirabegron—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000174	0.00468	CcSEcCtD
Mirabegron—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000173	0.00465	CcSEcCtD
Mirabegron—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000172	0.00464	CcSEcCtD
Mirabegron—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000172	0.00464	CcSEcCtD
Mirabegron—Eye disorder—Methotrexate—ankylosing spondylitis	0.00017	0.00459	CcSEcCtD
Mirabegron—Urticaria—Prednisolone—ankylosing spondylitis	0.000169	0.00456	CcSEcCtD
Mirabegron—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000169	0.00456	CcSEcCtD
Mirabegron—Fatigue—Triamcinolone—ankylosing spondylitis	0.000169	0.00455	CcSEcCtD
Mirabegron—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000169	0.00454	CcSEcCtD
Mirabegron—Hypertension—Prednisone—ankylosing spondylitis	0.000164	0.00442	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000162	0.00437	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000162	0.00437	CcSEcCtD
Mirabegron—Arthralgia—Prednisone—ankylosing spondylitis	0.000162	0.00435	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00016	0.00432	CcSEcCtD
Mirabegron—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00016	0.00431	CcSEcCtD
Mirabegron—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000157	0.00422	CcSEcCtD
Mirabegron—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000157	0.00422	CcSEcCtD
Mirabegron—Urticaria—Triamcinolone—ankylosing spondylitis	0.000156	0.0042	CcSEcCtD
Mirabegron—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000155	0.00419	CcSEcCtD
Mirabegron—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000155	0.00417	CcSEcCtD
Mirabegron—Infection—Prednisone—ankylosing spondylitis	0.000154	0.00415	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000154	0.00414	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000154	0.00414	CcSEcCtD
Mirabegron—Back pain—Methotrexate—ankylosing spondylitis	0.000153	0.00413	CcSEcCtD
Mirabegron—Fatigue—Dexamethasone—ankylosing spondylitis	0.000153	0.00413	CcSEcCtD
Mirabegron—Fatigue—Betamethasone—ankylosing spondylitis	0.000153	0.00413	CcSEcCtD
Mirabegron—Tachycardia—Prednisone—ankylosing spondylitis	0.000151	0.00407	CcSEcCtD
Mirabegron—Skin disorder—Prednisone—ankylosing spondylitis	0.00015	0.00405	CcSEcCtD
Mirabegron—Vision blurred—Methotrexate—ankylosing spondylitis	0.00015	0.00403	CcSEcCtD
Mirabegron—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000145	0.00392	CcSEcCtD
Mirabegron—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000145	0.00392	CcSEcCtD
Mirabegron—Urticaria—Dexamethasone—ankylosing spondylitis	0.000141	0.00381	CcSEcCtD
Mirabegron—Urticaria—Betamethasone—ankylosing spondylitis	0.000141	0.00381	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000141	0.0038	CcSEcCtD
Mirabegron—Dizziness—Prednisolone—ankylosing spondylitis	0.000141	0.0038	CcSEcCtD
Mirabegron—Asthenia—Triamcinolone—ankylosing spondylitis	0.000141	0.00379	CcSEcCtD
Mirabegron—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000141	0.00379	CcSEcCtD
Mirabegron—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000141	0.00379	CcSEcCtD
Mirabegron—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00014	0.00378	CcSEcCtD
Mirabegron—Pruritus—Triamcinolone—ankylosing spondylitis	0.000139	0.00374	CcSEcCtD
Mirabegron—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000138	0.00373	CcSEcCtD
Mirabegron—Dyspepsia—Prednisone—ankylosing spondylitis	0.000136	0.00367	CcSEcCtD
Mirabegron—Arthralgia—Methotrexate—ankylosing spondylitis	0.000135	0.00364	CcSEcCtD
Mirabegron—Rash—Prednisolone—ankylosing spondylitis	0.000134	0.00362	CcSEcCtD
Mirabegron—Dermatitis—Prednisolone—ankylosing spondylitis	0.000134	0.00362	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000134	0.00361	CcSEcCtD
Mirabegron—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000134	0.00361	CcSEcCtD
Mirabegron—Fatigue—Prednisone—ankylosing spondylitis	0.000134	0.0036	CcSEcCtD
Mirabegron—Headache—Prednisolone—ankylosing spondylitis	0.000134	0.0036	CcSEcCtD
Mirabegron—Constipation—Prednisone—ankylosing spondylitis	0.000132	0.00357	CcSEcCtD
Mirabegron—Dizziness—Triamcinolone—ankylosing spondylitis	0.00013	0.00349	CcSEcCtD
Mirabegron—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000129	0.00349	CcSEcCtD
Mirabegron—Infection—Methotrexate—ankylosing spondylitis	0.000129	0.00347	CcSEcCtD
Mirabegron—Asthenia—Betamethasone—ankylosing spondylitis	0.000128	0.00344	CcSEcCtD
Mirabegron—Asthenia—Dexamethasone—ankylosing spondylitis	0.000128	0.00344	CcSEcCtD
Mirabegron—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000127	0.00341	CcSEcCtD
Mirabegron—Nausea—Prednisolone—ankylosing spondylitis	0.000127	0.00341	CcSEcCtD
Mirabegron—Pruritus—Dexamethasone—ankylosing spondylitis	0.000126	0.00339	CcSEcCtD
Mirabegron—Pruritus—Betamethasone—ankylosing spondylitis	0.000126	0.00339	CcSEcCtD
Mirabegron—Skin disorder—Methotrexate—ankylosing spondylitis	0.000126	0.00339	CcSEcCtD
Mirabegron—Rash—Triamcinolone—ankylosing spondylitis	0.000124	0.00333	CcSEcCtD
Mirabegron—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000124	0.00333	CcSEcCtD
Mirabegron—Rash—Methylprednisolone—ankylosing spondylitis	0.000123	0.00332	CcSEcCtD
Mirabegron—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000123	0.00332	CcSEcCtD
Mirabegron—Urticaria—Prednisone—ankylosing spondylitis	0.000123	0.00332	CcSEcCtD
Mirabegron—Headache—Triamcinolone—ankylosing spondylitis	0.000123	0.00331	CcSEcCtD
Mirabegron—Headache—Methylprednisolone—ankylosing spondylitis	0.000123	0.0033	CcSEcCtD
Mirabegron—Abdominal pain—Prednisone—ankylosing spondylitis	0.000122	0.0033	CcSEcCtD
Mirabegron—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000122	0.00328	CcSEcCtD
Mirabegron—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000122	0.00328	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000118	0.00318	CcSEcCtD
Mirabegron—Dizziness—Dexamethasone—ankylosing spondylitis	0.000118	0.00317	CcSEcCtD
Mirabegron—Dizziness—Betamethasone—ankylosing spondylitis	0.000118	0.00317	CcSEcCtD
Mirabegron—Nausea—Triamcinolone—ankylosing spondylitis	0.000116	0.00314	CcSEcCtD
Mirabegron—Nausea—Methylprednisolone—ankylosing spondylitis	0.000116	0.00313	CcSEcCtD
Mirabegron—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000114	0.00307	CcSEcCtD
Mirabegron—Rash—Dexamethasone—ankylosing spondylitis	0.000112	0.00302	CcSEcCtD
Mirabegron—Rash—Betamethasone—ankylosing spondylitis	0.000112	0.00302	CcSEcCtD
Mirabegron—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000112	0.00302	CcSEcCtD
Mirabegron—Dermatitis—Betamethasone—ankylosing spondylitis	0.000112	0.00302	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000112	0.00301	CcSEcCtD
Mirabegron—Fatigue—Methotrexate—ankylosing spondylitis	0.000112	0.00301	CcSEcCtD
Mirabegron—Headache—Betamethasone—ankylosing spondylitis	0.000111	0.003	CcSEcCtD
Mirabegron—Headache—Dexamethasone—ankylosing spondylitis	0.000111	0.003	CcSEcCtD
Mirabegron—Asthenia—Prednisone—ankylosing spondylitis	0.000111	0.00299	CcSEcCtD
Mirabegron—Pruritus—Prednisone—ankylosing spondylitis	0.00011	0.00295	CcSEcCtD
Mirabegron—Diarrhoea—Prednisone—ankylosing spondylitis	0.000106	0.00286	CcSEcCtD
Mirabegron—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000106	0.00285	CcSEcCtD
Mirabegron—Nausea—Dexamethasone—ankylosing spondylitis	0.000106	0.00285	CcSEcCtD
Mirabegron—Nausea—Betamethasone—ankylosing spondylitis	0.000106	0.00285	CcSEcCtD
Mirabegron—Urticaria—Methotrexate—ankylosing spondylitis	0.000103	0.00277	CcSEcCtD
Mirabegron—Dizziness—Prednisone—ankylosing spondylitis	0.000102	0.00276	CcSEcCtD
Mirabegron—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000102	0.00276	CcSEcCtD
Mirabegron—Rash—Prednisone—ankylosing spondylitis	9.77e-05	0.00263	CcSEcCtD
Mirabegron—Dermatitis—Prednisone—ankylosing spondylitis	9.76e-05	0.00263	CcSEcCtD
Mirabegron—Headache—Prednisone—ankylosing spondylitis	9.71e-05	0.00262	CcSEcCtD
Mirabegron—Asthenia—Methotrexate—ankylosing spondylitis	9.29e-05	0.0025	CcSEcCtD
Mirabegron—Nausea—Prednisone—ankylosing spondylitis	9.2e-05	0.00248	CcSEcCtD
Mirabegron—Pruritus—Methotrexate—ankylosing spondylitis	9.16e-05	0.00247	CcSEcCtD
Mirabegron—Diarrhoea—Methotrexate—ankylosing spondylitis	8.86e-05	0.00239	CcSEcCtD
Mirabegron—Dizziness—Methotrexate—ankylosing spondylitis	8.56e-05	0.00231	CcSEcCtD
Mirabegron—Rash—Methotrexate—ankylosing spondylitis	8.16e-05	0.0022	CcSEcCtD
Mirabegron—Dermatitis—Methotrexate—ankylosing spondylitis	8.16e-05	0.0022	CcSEcCtD
Mirabegron—Headache—Methotrexate—ankylosing spondylitis	8.11e-05	0.00219	CcSEcCtD
Mirabegron—Nausea—Methotrexate—ankylosing spondylitis	7.69e-05	0.00207	CcSEcCtD
